California Voters Divided in Support of Ballot Measure That Would Fund Stem Cell Research
By Kaiser Daily Women's Health Policy Report,
Kaiser Daily Women's Health Policy Report
| 08. 16. 2004
California voters are "almost evenly divided" on a ballot measure that would provide the state with nearly $3 billion in funding for human embryonic stem cell research, according to a Field Poll survey released on Sunday, Reuters reports (Reuters, 8/15). Under the measure, which will appear on the Nov. 2 ballot as Proposition 71, the California Stem Cell Research and Cures Initiative, organized by Californians for Stem Cell Research and Cures, would provide $295 million in state funds annually for 10 years to California schools, institutes and companies that conduct embryonic stem cell research. The initiative would provide grants and loans to organizations that use stem cells derived from human embryos that are less than two weeks old. The measure also would create a 29-member panel -- appointed by the governor, University of California chancellors and other officials -- that would determine allocation of the grants, which would be provided only to California organizations. If the ballot measure is successful, California would become the first state to publicly fund embryonic stem cell research, which some scientists believe...
Related Articles
By Editors, Nature | 08.18.2026
Shinya Yamanaka doesn’t see himself as a celebrity. But people do recognize the stem-cell researcher when he’s out for a run, often while training for a marathon, on the streets of Kyoto, Japan.
Many of them call out words of...
By Jessica Hamzelou, MIT Technology Review | 07.30.2026
As of this week in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers. Companies whose drugs have been through preliminary testing—sometimes in as few as 10 healthy people—can pay $12,500 to...
By Carl Zimmer and Marco Hernandez , The New York Times | 07.01.2026
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...